title: EMA provides first glimpse of PRIME candidates.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017277:Drug Approval; D005062:European Union; D006801:Humans; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D051359:Lymphohistiocytosis, Hemophagocytic / Q000188:drug therapy; D016393:Lymphoma, B-Cell / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D007371:Interferon-gamma